Integra Med Analytics Files Whistleblower Lawsuit against Providence Health & Services and J.A. Thomas and Associates

Filing marks shift in nature of healthcare litigation of this nature.

The whistleblower cases I report on for RACmonitor typically are brought by the quintessential whistleblower – a healthcare industry insider who has observed first-hand fraud perpetrated by his or her employer and who, having brought the matter to the employer’s attention for redress and been rebuffed, participates in a False Claims Act (FCA) claim on the government’s behalf.

For instance, in May I reported on the federal government’s settlement of a False Claims Act case against Banner Health that was brought by whistleblower Cecilia Guardiola, Banner’s former corporate director of clinical documentation, for practices she uncovered in the course of her duties. The information a whistleblower insider like Ms. Guardiola provides is invaluable, precisely because it comes from the inside and can help prosecutors establish that, instead of resulting from an innocent mistake, the employer’s fraudulent practices were committed knowingly.

However, the recent lawsuit against Providence Health & Services (Providence) and its consultant J.A. Thomas and Associates LLC (JATA) is different. It is part of a new breed of whistleblower cases in which the whistleblower is an outsider – a third-party expert with subject matter knowledge in the field who is viewing the target defendant largely from the outside. Instead of an individual employee of defendants Providence or JATA, Integra Med Analytics LLC, the whistleblower here, is a data analysis firm that uses statistical analysis of publicly available data to attempt to uncover and prove fraud.

In this case, Integra alleges that it conducted an analysis of seven years’ worth of Centers for Medicare & Medicaid Services (CMS) claims data (from 2011 to 2017) for a subset of Providence hospitals using JATA as a consultant and found that those Providence hospitals were statistically more likely than other hospitals to add to a hospital claim three secondary diagnoses – encephalopathy, respiratory failure, and malnutrition – that can increase a hospital’s Medicare payments by $1,000 to $25,000 per claim.  

It is notable that Integra does not rely exclusively on its outside evidence – that is, its statistical analyses of public data – to allege fraud against Providence and JATA. In its complaint, Integra acknowledges that it supplemented its analysis of CMS claims data (which uncovered a statistically significant pattern with the hallmarks of fraud) with more traditional, classic “inside” information and thereby confirmed its findings. According to its complaint, Integra conducted what it describes as an exhaustive, multi-faceted investigation whereby it interviewed former employees of Providence and JATA and reviewed their marketing materials to show Providence’s alleged false claims were not only intentional, but part of a systemic effort to boost Medicare revenue. Integra’s complaint is replete with references to internal documents, presumably provided by the former employee insiders Integra interviewed, allegedly containing examples of JATA coaching and steering Providence doctors to upcode for CCs (complications or comorbidities) and MCCs (major CCs).

To date, the press coverage has emphasized the more ground breaking part of Integra’s case – the fact Integra uncovered the alleged fraud via independent analysis of CMS data – while ignoring the fact that Integra supplemented this evidence with more traditional inside information gathered through a private investigation, which is the hallmark of most whistleblower cases. In this way, Integra is more of a hybrid outsider/insider whistleblower, or a case of “whistleblower outsider-plus” – the plus factor being an injection of information gained from the inside showing defendants’ purported knowledge of the practices to bolster the allegations otherwise arising from public records.    

Since the federal government has declined to join Integra’s whistleblower case, Integra is invoking its right as a whistleblower under the False Claims Act to proceed with a declined case on the government’s behalf. We will continue to follow this case as it progresses. However, in the meantime, keep your eyes open for more False Claims Act cases from hybrid whistleblower insiders/outsiders, including Integra’s sister company, Integra REC LLC, which, according to the Providence complaint, also has served as a whistleblower and successfully initiated numerous FCA cases alleging fraud in mortgage-backed securities and other financial markets. Hybrid whistleblowers appear to be on the rise.

 

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn
Email
Print

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Mastering the Two-Midnight Rule: Keys to Navigating Short-Stay Admissions with Confidence

Mastering the Two-Midnight Rule: Keys to Navigating Short-Stay Admissions with Confidence

The CMS Two-Midnight Rule and short-stay audits are here to stay, impacting inpatient and outpatient admissions, ASC procedures, and Medicare Parts C & D. New for 2024, the Two-Midnight Rule applies to Medicare Advantage patients, requiring differentiation between Medicare plans affecting Case Managers, Utilization Review, and operational processes and knowledge of a vital distinction between these patients that influences post-discharge medical reviews and compliance risk. Join Michael G. Calahan for a comprehensive webcast covering federal laws for all admission processes. Gain the knowledge needed to navigate audits effectively and optimize patient access points, personnel, and compliance strategies. Learn Two-Midnight Rule essentials, Medicare Advantage implications, and compliance best practices. Discover operational insights for short-stay admissions, outpatient observation, and the ever-changing Inpatient-Only Listing.

Print Friendly, PDF & Email
September 19, 2023
Secondary Diagnosis Coding: A Deep Dive into Guidelines and Best Practices

Secondary Diagnosis Coding: A Deep Dive into Guidelines and Best Practices

Explore comprehensive guidelines and best practices for secondary diagnosis coding in our illuminating webcast. Delve into the intricacies of accurately assigning secondary diagnosis codes to ensure precise medical documentation. Learn how to navigate complex scenarios and adhere to coding regulations while enhancing coding proficiency. Our expert-led webcast covers essential insights, including documentation requirements, sequencing strategies, and industry updates. Elevate your coding skills and stay current with the latest coding advancements so you can determine the correct DRG assignment to optimize reimbursement, support medical decision-making, and maintain compliance.

Print Friendly, PDF & Email
September 20, 2023
Principal Diagnosis Coding: Mastering Selection and Sequencing

Principal Diagnosis Coding: Mastering Selection and Sequencing

Enhance your inpatient coding precision and revenue with Principal Diagnosis Coding: Mastering Selection and Sequencing. Join our expert-led webcast to conquer the challenges of principal diagnosis selection and sequencing. We’ll decode the intricacies of ICD-10-CM guidelines, equipping you with a clear grasp of the rules and the official UHDDS principal diagnosis definition. Uncover the crucial role of coding conventions, master the sequencing of related conditions, and confidently tackle cases with equally valid principal diagnoses.

Print Friendly, PDF & Email
September 14, 2023
2024 IPPS Summit: Final Rule Update with Expert Insights and Analysis

2024 IPPS Summit: Final Rule Update with Expert Insights and Analysis

Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY24 Inpatient Prospective Payment System (IPPS) Final Rule, including new ICD-10-CM/PCS codes, plus insights, analysis and answers to questions from the country’s most respected subject matter experts.

Print Friendly, PDF & Email
2024 IPPS Summit Day 3: MS-DRG Shifts and NTAPs

2024 IPPS Summit Day 3: MS-DRG Shifts and NTAPs

This third session in our 2024 IPPS Summit will feature a review of FY24 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by senior healthcare consultant Laurie Johnson, with bonus insights and analysis from two acclaimed subject matter experts

Print Friendly, PDF & Email
August 17, 2023

Trending News